stars 1 stars 2 stars 3

Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in the regenerative medicine, disease research and animal agriculture. Led by a team of expert geneticists, genome engineers, and reproductive physiologists, the company is headquartered in St. Paul, Minnesota.

Recombinetics Questions

The Recombinetics annual revenue was $25 million in 2026.

Rocco Morelli is the CEO of Recombinetics.

12 people are employed at Recombinetics.

Recombinetics is based in Eagan, Minnesota.

The NAICS codes for Recombinetics are [54, 541714, 5417, 541, 54171].

The SIC codes for Recombinetics are [87, 873].

Top Recombinetics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users